R&Co Risk-Based International Index – Weighting
Total Page：16
File Type：pdf, Size：1020Kb
Load more
Recommended publications
-
Japanese Manufacturing Affiliates in Europe and Turkey
06-ORD 70H-002AA 7 Japanese Manufacturing Affiliates in Europe and Turkey - 2005 Survey - September 2006 Japan External Trade Organization (JETRO) Preface The survey on “Japanese manufacturing affiliates in Europe and Turkey” has been conducted 22 times since the first survey in 1983*. The latest survey, carried out from January 2006 to February 2006 targeting 16 countries in Western Europe, 8 countries in Central and Eastern Europe, and Turkey, focused on business trends and future prospects in each country, procurement of materials, production, sales, and management problems, effects of EU environmental regulations, etc. The survey revealed that as of the end of 2005 there were a total of 1,008 Japanese manufacturing affiliates operating in the surveyed region --- 818 in Western Europe, 174 in Central and Eastern Europe, and 16 in Turkey. Of this total, 291 affiliates --- 284 in Western Europe, 6 in Central and Eastern Europe, and 1 in Turkey --- also operate R & D or design centers. Also, the number of Japanese affiliates who operate only R & D or design centers in the surveyed region (no manufacturing operations) totaled 129 affiliates --- 125 in Western Europe and 4 in Central and Eastern Europe. In this survey we put emphasis on the effects of EU environmental regulations on Japanese manufacturing affiliates. We would like to express our great appreciation to the affiliates concerned for their kind cooperation, which have enabled us over the years to constantly improve the survey and report on the results. We hope that the affiliates and those who are interested in business development in Europe and/or Turkey will find this report useful. -
Large Firm Dynamics and Secular Stagnation: Evidence from Japan and the U.S
Bank of Japan Working Paper Series Large Firm Dynamics and Secular Stagnation: Evidence from Japan and the U.S. Yoshihiko Hogen* [email protected] Ko Miura** [email protected] Koji Takahashi*** [email protected] No.17-E-8 Bank of Japan June 2017 2-1-1 Nihonbashi-Hongokucho, Chuo-ku, Tokyo 103-0021, Japan ***Research and Statistics Department (currently at the Monetary Affairs Department) *** Research and Statistics Department *** Research and Statistics Department (currently at the Financial System and Bank Examination Department) Papers in the Bank of Japan Working Paper Series are circulated in order to stimulate discussion and comments. Views expressed are those of authors and do not necessarily reflect those of the Bank. If you have any comment or question on the working paper series, please contact each author. When making a copy or reproduction of the content for commercial purposes, please contact the Public Relations Department ([email protected]) at the Bank in advance to request permission. When making a copy or reproduction, the source, Bank of Japan Working Paper Series, should explicitly be credited. Large Firm Dynamics and Secular Stagnation: Evidence from Japan and the U.S. Yoshihiko Hogeny Ko Miuraz Koji Takahashix June 2017 Abstract Focusing on the recent secular stagnation debate, this paper examines the role of large …rm dynamics as determinants of productivity ‡uctuations. We …rst show that idiosyncratic shocks to large …rms as well as entry, exit, and reallocation e¤ects account for 30 to 40 percent of productivity ‡uctuations in Japan and the U.S. -
View a Copy of This Licence, Visit Tivecommons.Org/Licenses/By/4.0
Katakami et al. Cardiovasc Diabetol (2020) 19:110 https://doi.org/10.1186/s12933-020-01079-4 Cardiovascular Diabetology ORIGINAL INVESTIGATION Open Access Tofoglifozin does not delay progression of carotid atherosclerosis in patients with type 2 diabetes: a prospective, randomized, open-label, parallel-group comparative study Naoto Katakami1,2* , Tomoya Mita3, Hidenori Yoshii4, Toshihiko Shiraiwa5, Tetsuyuki Yasuda6, Yosuke Okada7, Keiichi Torimoto7, Yutaka Umayahara8, Hideaki Kaneto9, Takeshi Osonoi10, Tsunehiko Yamamoto11, Nobuichi Kuribayashi12, Kazuhisa Maeda13, Hiroki Yokoyama14, Keisuke Kosugi15, Kentaro Ohtoshi16, Isao Hayashi17, Satoru Sumitani18, Mamiko Tsugawa19, Kayoko Ryomoto20, Hideki Taki21, Tadashi Nakamura22, Satoshi Kawashima23, Yasunori Sato24, Hirotaka Watada3 and Iichiro Shimomura1 on behalf of the UTOPIA study investigators Abstract Background: This study aimed to investigate the preventive efects of tofoglifozin, a selective sodium-glucose cotransporter 2 (SGLT2) inhibitor, on atherosclerosis progression in type 2 diabetes (T2DM) patients without apparent cardiovascular disease (CVD) by monitoring carotid intima-media thickness (IMT). Methods: This prospective, randomized, open-label, blinded-endpoint, multicenter, parallel-group, comparative study included 340 subjects with T2DM and no history of apparent CVD recruited at 24 clinical units. Subjects were randomly allocated to either the tofoglifozin treatment group (n 169) or conventional treatment group using drugs other than SGLT2 inhibitors (n 171). Primary outcomes were changes= in mean and maximum common carotid IMT measured by echography during= a 104-week treatment period. Results: In a mixed-efects model for repeated measures, the mean IMT of the common carotid artery (mean- IMT-CCA), along with the right and left maximum IMT of the CCA (max-IMT-CCA), signifcantly declined in both the tofoglifozin ( 0.132 mm, SE 0.007; 0.163 mm, SE 0.013; 0.170 mm, SE 0.020, respectively) and the control group ( 0.140 mm,− SE 0.006; 0.190 mm,− SE 0.012; 0.190 mm,− SE 0.020, respectively). -
Templeton Global Equity Income Fund August 31, 2021
FTIF - Templeton Global Equity Income Fund August 31, 2021 FTIF - Templeton Global Equity August 31, 2021 Income Fund Portfolio Holdings The following portfolio data for the Franklin Templeton funds is made available to the public under our Portfolio Holdings Release Policy and is "as of" the date indicated. This portfolio data should not be relied upon as a complete listing of a fund's holdings (or of a fund's top holdings) as information on particular holdings may be withheld if it is in the fund's interest to do so. Additionally, foreign currency forwards are not included in the portfolio data. Instead, the net market value of all currency forward contracts is included in cash and other net assets of the fund. Further, portfolio holdings data of over-the-counter derivative investments such as Credit Default Swaps, Interest Rate Swaps or other Swap contracts list only the name of counterparty to the derivative contract, not the details of the derivative. Complete portfolio data can be found in the semi- and annual financial statements of the fund. Security Security Shares/ Market % of Coupon Maturity Identifier Name Positions Held Value TNA Rate Date B4TX8S1 AIA GROUP LTD 70,295 $839,367 1.10% N/A N/A 012653101 ALBEMARLE CORP 7,404 $1,752,822 2.31% N/A N/A 025816109 AMERICAN EXPRESS CO 12,293 $2,040,146 2.68% N/A N/A BYPBS67 ARCELORMITTAL SA 14,303 $479,701 0.63% N/A N/A 0989529 ASTRAZENECA PLC 11,321 $1,323,868 1.74% N/A N/A 084670702 BERKSHIRE HATHAWAY INC 2,308 $659,557 0.87% N/A N/A 09857L108 BOOKING HOLDINGS INC 520 $1,195,828 1.57% -
ESG in Japan: Misunderstood & Underestimated
ESG in Japan: Misunderstood & Underestimated Comgest’s investment approach is grounded on thorough fundamental analysis carried out by experienced portfolio managers located in the markets where they invest. Seasoned investors who spend years researching and building relationships with local companies develop an understanding of cultural and regional nuances that are not obvious to outsiders. We believe this leads to perceptive investment insights that few other firms can match. This white paper, authored by Comgest PM Richard Kaye who has spent almost three decades living and investing in Japan, illustrates how experienced local investors can spot opportunities that others miss. Richard Kaye Analyst / Portfolio Manager, Japan Japan is in the process of being rediscovered after a “lost generation” in which it was largely neglected by both domestic Richard Kaye joined Comgest in 2009 and international asset allocators. However, despite the renewed and is a Tokyo-based Analyst and interest in this fascinating and broad market, international investors Portfolio Manager specialising in remain wary of corporate Japan’s ESG credentials. Japanese Japanese equities. With a wealth of companies have a reputation for being behind their global experience in Japanese equities, peers when it comes to ESG activities and transparency. We Richard became co-lead of Comgest’s believe that this characterisation is misleading: many Japanese Japan equity strategy upon joining the companies appear to be ahead of the rest of the world in terms of Group. He started his career in 1994 as environmental technologies and have a deep commitment to their an Analyst with the Industrial Bank of founding vision and social purpose. -
Published on July 21, 2021 1. Changes in Constituents 2
Results of the Periodic Review and Component Stocks of Tokyo Stock Exchange Dividend Focus 100 Index (Effective July 30, 2021） Published on July 21, 2021 1. Changes in Constituents Addition（18） Deletion（18） CodeName Code Name 1414SHO-BOND Holdings Co.,Ltd. 1801 TAISEI CORPORATION 2154BeNext-Yumeshin Group Co. 1802 OBAYASHI CORPORATION 3191JOYFUL HONDA CO.,LTD. 1812 KAJIMA CORPORATION 4452Kao Corporation 2502 Asahi Group Holdings,Ltd. 5401NIPPON STEEL CORPORATION 4004 Showa Denko K.K. 5713Sumitomo Metal Mining Co.,Ltd. 4183 Mitsui Chemicals,Inc. 5802Sumitomo Electric Industries,Ltd. 4204 Sekisui Chemical Co.,Ltd. 5851RYOBI LIMITED 4324 DENTSU GROUP INC. 6028TechnoPro Holdings,Inc. 4768 OTSUKA CORPORATION 6502TOSHIBA CORPORATION 4927 POLA ORBIS HOLDINGS INC. 6503Mitsubishi Electric Corporation 5105 Toyo Tire Corporation 6988NITTO DENKO CORPORATION 5301 TOKAI CARBON CO.,LTD. 7011Mitsubishi Heavy Industries,Ltd. 6269 MODEC,INC. 7202ISUZU MOTORS LIMITED 6448 BROTHER INDUSTRIES,LTD. 7267HONDA MOTOR CO.,LTD. 6501 Hitachi,Ltd. 7956PIGEON CORPORATION 7270 SUBARU CORPORATION 9062NIPPON EXPRESS CO.,LTD. 8015 TOYOTA TSUSHO CORPORATION 9101Nippon Yusen Kabushiki Kaisha 8473 SBI Holdings,Inc. 2.Dividend yield (estimated) 3.50% 3. Constituent Issues (sort by local code) No. local code name 1 1414 SHO-BOND Holdings Co.,Ltd. 2 1605 INPEX CORPORATION 3 1878 DAITO TRUST CONSTRUCTION CO.,LTD. 4 1911 Sumitomo Forestry Co.,Ltd. 5 1925 DAIWA HOUSE INDUSTRY CO.,LTD. 6 1954 Nippon Koei Co.,Ltd. 7 2154 BeNext-Yumeshin Group Co. 8 2503 Kirin Holdings Company,Limited 9 2579 Coca-Cola Bottlers Japan Holdings Inc. 10 2914 JAPAN TOBACCO INC. 11 3003 Hulic Co.,Ltd. 12 3105 Nisshinbo Holdings Inc. 13 3191 JOYFUL HONDA CO.,LTD. -
Response: Just Eat Takeaway.Com N. V
NON- CONFIDENTIAL JUST EAT TAKEAWAY.COM Submission to the CMA in response to its request for views on its Provisional Findings in relation to the Amazon/Deliveroo merger inquiry 1 INTRODUCTION AND BACKGROUND 1. In line with the Notice of provisional findings made under Rule 11.3 of the Competition and Markets Authority ("CMA") Rules of Procedure published on the CMA website, Just Eat Takeaway.com N.V. ("JETA") submits its views on the provisional findings of the CMA dated 16 April 2020 (the "Provisional Findings") regarding the anticipated acquisition by Amazon.com BV Investment Holding LLC, a wholly-owned subsidiary of Amazon.com, Inc. ("Amazon") of certain rights and minority shareholding of Roofoods Ltd ("Deliveroo") (the "Transaction"). 2. In the Provisional Findings, the CMA has concluded that the Transaction would not be expected to result in a substantial lessening of competition ("SLC") in either the market for online restaurant platforms or the market for online convenience groceries ("OCG")1 on the basis that, as a result of the Coronavirus ("COVID-19") crisis, Deliveroo is likely to exit the market unless it receives the additional funding available through the Transaction. The CMA has also provisionally found that no less anti-competitive investors were available. 3. JETA considers that this is an unprecedented decision by the CMA and questions whether it is appropriate in the current market circumstances. In its Phase 1 Decision, dated 11 December 20192, the CMA found that the Transaction gives rise to a realistic prospect of an SLC as a result of horizontal effects in the supply of food platforms and OCG in the UK. -
Convocation Notice of the 11Th Ordinary General Meeting of Shareholders
THE FOLLOWING IS AN ENGLISH TRANSLATION PREPARED FOR THE CONVENIENCE OF THE SHAREHOLDERS AND INVESTORS. THE OFFICIAL TEXT IN JAPANESE OF THE CONVOCATION NOTICE OF THE ORDINARY GENERAL MEETING OF SHAREHOLDERS HAS BEEN PREPARED IN ACCORDANCE WITH STATUTORY PROVISIONS AND MAILED TO THE RESPECTIVE SHAREHOLDERS. SHOULD THERE BE ANY INCONSISTENCY BETWEEN THE TRANSLATION AND THE OFFICIAL TEXT IN TERMS OF THE CONTENTS OF THE NOTICE, THE OFFICIAL TEXT SHALL PREVAIL. THE COMPANY ACCEPTS NO LIABILITY FOR ANY MISUNDERSTANDING CAUSED BY THE TRANSLATION FOR ANY REASON WHATSOEVER. CONVOCATION NOTICE OF THE 11TH ORDINARY GENERAL MEETING OF SHAREHOLDERS Date and Time: Friday June 25, 2021 at 10:00 a.m. (Reception will open at 9:00 a.m.) Place: Ball Room “Aoi,” Second Floor, Palace Hotel Tokyo A Request to Our Shareholders 1-1, Marunouchi 1-chome, Chiyoda-ku, Tokyo █ This ordinary general meeting of shareholders is to be held Deadline for Exercise of Voting Right(s) in Writing or via the by taking as many measures as possible to prevent the Internet: spread of infection of COVID-19 and ensure safety of Thursday, June 24, 2021 until 5:30 p.m. shareholders. Matters to be Resolved: █ As shareholders may exercise their voting right(s) in Proposal 1: Appropriation of Surplus advance in writing or via the Internet, we strongly Proposal 2: Election of 11 Directors who are not Audit and encourage you to make use of these options, and to refrain Supervisory Committee Members from attending the meeting in person on the day. Proposal 3: Election of 2 Directors who are Audit and █ If you are found to have a fever or appear to be unwell Supervisory Committee Members when you arrive at the venue, you may be refused entry. -
FTSE Japan ESG Low Carbon Select
2 FTSE Russell Publications 19 August 2021 FTSE Japan ESG Low Carbon Select Indicative Index Weight Data as at Closing on 30 June 2021 Constituent Index weight (%) Country Constituent Index weight (%) Country Constituent Index weight (%) Country ABC-Mart 0.01 JAPAN Ebara 0.17 JAPAN JFE Holdings 0.04 JAPAN Acom 0.02 JAPAN Eisai 1.03 JAPAN JGC Corp 0.02 JAPAN Activia Properties 0.01 JAPAN Eneos Holdings 0.05 JAPAN JSR Corp 0.11 JAPAN Advance Residence Investment 0.01 JAPAN Ezaki Glico 0.01 JAPAN JTEKT 0.07 JAPAN Advantest Corp 0.53 JAPAN Fancl Corp 0.03 JAPAN Justsystems 0.01 JAPAN Aeon 0.61 JAPAN Fanuc 0.87 JAPAN Kagome 0.02 JAPAN AEON Financial Service 0.01 JAPAN Fast Retailing 3.13 JAPAN Kajima Corp 0.1 JAPAN Aeon Mall 0.01 JAPAN FP Corporation 0.04 JAPAN Kakaku.com Inc. 0.05 JAPAN AGC 0.06 JAPAN Fuji Electric 0.18 JAPAN Kaken Pharmaceutical 0.01 JAPAN Aica Kogyo 0.07 JAPAN Fuji Oil Holdings 0.01 JAPAN Kamigumi 0.01 JAPAN Ain Pharmaciez <0.005 JAPAN FUJIFILM Holdings 1.05 JAPAN Kaneka Corp 0.01 JAPAN Air Water 0.01 JAPAN Fujitsu 2.04 JAPAN Kansai Paint 0.05 JAPAN Aisin Seiki Co 0.31 JAPAN Fujitsu General 0.01 JAPAN Kao 1.38 JAPAN Ajinomoto Co 0.27 JAPAN Fukuoka Financial Group 0.01 JAPAN KDDI Corp 2.22 JAPAN Alfresa Holdings 0.01 JAPAN Fukuyama Transporting 0.01 JAPAN Keihan Holdings 0.02 JAPAN Alps Alpine 0.04 JAPAN Furukawa Electric 0.03 JAPAN Keikyu Corporation 0.02 JAPAN Amada 0.01 JAPAN Fuyo General Lease 0.08 JAPAN Keio Corp 0.04 JAPAN Amano Corp 0.01 JAPAN GLP J-REIT 0.02 JAPAN Keisei Electric Railway 0.03 JAPAN ANA Holdings 0.02 JAPAN GMO Internet 0.01 JAPAN Kenedix Office Investment Corporation 0.01 JAPAN Anritsu 0.15 JAPAN GMO Payment Gateway 0.01 JAPAN KEWPIE Corporation 0.03 JAPAN Aozora Bank 0.02 JAPAN Goldwin 0.01 JAPAN Keyence Corp 0.42 JAPAN As One 0.01 JAPAN GS Yuasa Corp 0.03 JAPAN Kikkoman 0.25 JAPAN Asahi Group Holdings 0.5 JAPAN GungHo Online Entertainment 0.01 JAPAN Kinden <0.005 JAPAN Asahi Intecc 0.01 JAPAN Gunma Bank 0.01 JAPAN Kintetsu 0.03 JAPAN Asahi Kasei Corporation 0.26 JAPAN H.U. -
Daiichi Sankyo Company, Limited
[Translation] CONVOCATION NOTICE OF THE 14TH ORDINARY GENERAL MEETING OF SHAREHOLDERS For the Fiscal Year Ended March 31, 2019 Daiichi Sankyo Company, Limited *Note: This translation does not include pictures, charts etc. originally issued in the Japanese version. - 1 - [Translation] To Our Shareholders At the Daiichi Sankyo Group (“the Group”), we are proceeding with the initiatives of 4th mid- term business plan with the aim of becoming a “Global Pharma Innovator with Competitive Advantage in Oncology” as set forth in our 2025 Vision. In fiscal 2018, we made significant progress in developing new drugs in oncology area, including DS-8201, an antibody drug conjugates utilizing our proprietary technologies. In addition, we entered into a strategic collaboration agreement with AstraZeneca, which has strengths in the oncology business, for the global development and commercialization of DS-8201 in order to maximize its value. Furthermore, sales of mainstay products such as edoxaban, an anticoagulant which supports current earnings of the Group, were firm in Japan and overseas. The achievement of initial target of mid-term business plan for fiscal 2020 is expected to be delayed by two years due to failure of achievement of the plan for pain franchise business and additional investments in research and development. However, we are gaining confidence of achieving our 2025 Vision and accelerating growth in the future due to the significant improvement in the value of oncology area pipelines. We will continue to make every effort to achieve the goals of the Medium-Term Management Plan and 2025 Vision. I greatly appreciate your continued support in the future. -
Daiichi Sankyo Group Value Report 2019
External Evaluations (as of June 30,2019) ™ Daiichi Sankyo Group Value Report 2019 Value Daiichi Sankyo Group MSCI Japan Empowering Women Select Index THE INCLUSION OF DAIICHI SANKYO CO.,LTD. IN ANY MSCI INDEX, AND THE USE OF MSCI LOGOS, TRADEMARKS, SERVICE MARKS OR INDEX NAMES HEREIN, DO NOT CONSTITUTE A SPONSORSHIP, ENDORSEMENT OR PROMOTION OF DAIICHI SANKYO CO.,LTD. BY MSCI OR ANY OF ITS AFFILIATES. THE MSCI INDEXES ARE THE EXCLUSIVE PROPERTY OF MSCI. MSCI AND THE MSCI INDEX NAMES AND LOGOS ARE TRADE- MARKS OR SERVICE MARKS OF MSCI OR ITS AFFILIATES. “Eruboshi” Certification Mark “Kurumin” Certification Mark Logo given to Certified Health and Productivity Management Organization (White500) This report uses FSC® certified paper, which indicates that the paper used to print this Paper report was produced from properly managed forests. 3-5-1, Nihonbashi-honcho, Chuo-ku, Tokyo 103-8426, Japan This report was printed using 100% Inks biodegradable printing inks from vegetable Corporate Communications Department oil. Daiichi Sankyo Group Tel: +81-3-6225-1126 CSR Department The waterless printing method used for this Value Report 2019 Tel: +81-3-6225-1067 Printing report minimized the use and release of harmful liquid wastes. https://www.daiichisankyo.com/ Printed in Japan 005_7045687911909.indd 1 2019/09/27 18:22:19 Introduction Our Mission The Core Values and Commitments serve as the criteria for business activities and In addition, we have established the DAIICHI SANKYO Group Corporate Conduct Charter . decision-making used by executive officers and employees in working to fulfill Our Mission . This charter calls on us to fulfill our social responsibilities by acting with the highest ethical Our Corporate Slogan succinctly explains the spirit of Our Mission, Core Values and standards and a good social conscience appropriate for a company engaged in business Commitments. -
Itraxx Japan Series 35 Final Membership List March 2021
iTraxx Japan Series 35 Final Membership List March 2021 Copyright © 2021 IHS Markit Ltd T180614 iTraxx Japan Series 35 Final Membership List 1 iTraxx Japan Series 35 Final Membership List...........................................3 2 iTraxx Japan Series 35 Final vs. Series 34................................................ 5 3 Further information .....................................................................................6 Copyright © 2021 IHS Markit Ltd | 2 T180614 iTraxx Japan Series 35 Final Membership List 1 iTraxx Japan Series 35 Final Membership List IHS Markit Ticker IHS Markit Long Name ACOM ACOM CO., LTD. JUSCO AEON CO., LTD. ANAHOL ANA HOLDINGS INC. FUJITS FUJITSU LIMITED HITACH HITACHI, LTD. HNDA HONDA MOTOR CO., LTD. CITOH ITOCHU CORPORATION JAPTOB JAPAN TOBACCO INC. JFEHLD JFE HOLDINGS, INC. KAWHI KAWASAKI HEAVY INDUSTRIES, LTD. KAWKIS KAWASAKI KISEN KAISHA, LTD. KINTGRO KINTETSU GROUP HOLDINGS CO., LTD. KOBSTL KOBE STEEL, LTD. KOMATS KOMATSU LTD. MARUB MARUBENI CORPORATION MITCO MITSUBISHI CORPORATION MITHI MITSUBISHI HEAVY INDUSTRIES, LTD. MITSCO MITSUI & CO., LTD. MITTOA MITSUI CHEMICALS, INC. MITSOL MITSUI O.S.K. LINES, LTD. NECORP NEC CORPORATION NPG-NPI NIPPON PAPER INDUSTRIES CO.,LTD. NIPPSTAA NIPPON STEEL CORPORATION NIPYU NIPPON YUSEN KABUSHIKI KAISHA NSANY NISSAN MOTOR CO., LTD. OJIHOL OJI HOLDINGS CORPORATION ORIX ORIX CORPORATION PC PANASONIC CORPORATION RAKUTE RAKUTEN, INC. RICOH RICOH COMPANY, LTD. SHIMIZ SHIMIZU CORPORATION SOFTGRO SOFTBANK GROUP CORP. SNE SONY CORPORATION Copyright © 2021 IHS Markit Ltd | 3 T180614 iTraxx Japan Series 35 Final Membership List SUMICH SUMITOMO CHEMICAL COMPANY, LIMITED SUMI SUMITOMO CORPORATION SUMIRD SUMITOMO REALTY & DEVELOPMENT CO., LTD. TFARMA TAKEDA PHARMACEUTICAL COMPANY LIMITED TOKYOEL TOKYO ELECTRIC POWER COMPANY HOLDINGS, INCORPORATED TOSH TOSHIBA CORPORATION TOYOTA TOYOTA MOTOR CORPORATION Copyright © 2021 IHS Markit Ltd | 4 T180614 iTraxx Japan Series 35 Final Membership List 2 iTraxx Japan Series 35 Final vs.